Developing affordable methods for creating modified DNA
Official title: Innovations to expand and accelerate the commercial impact of DNA modifications
Funded at Dnali Data Technologies, INC. · NIH-10922503 · Data updated 2026-11-12
This study is working on a new, eco-friendly way to make special types of DNA that can help scientists better understand health and develop new treatments, which could lead to improved tests and therapies for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dnali Data Technologies, INC. NIH-funded |
| Lab location | 1 site (Cary, United States) |
| Project start | June 15, 2024 |
| Project end | May 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $399,538 |
| NIH project number | 1R41HG013877-01 |
| Project ID | NIH-10922503 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals involved in or affected by conditions that require advanced genetic testing or therapies utilizing modified DNA.
✕Less likely to help
Patients who do not require genetic testing or therapies involving DNA modifications may not benefit from this research.
What this research studies
This research focuses on improving the synthesis of chemically modified DNA, which is crucial for understanding biological processes and developing biomedical applications. The team has created a new technology that uses sustainable enzymatic methods to produce modified DNA at a lower cost and under milder conditions compared to traditional methods. By addressing the limitations of current synthesis techniques, the project aims to make a wider variety of DNA modifications accessible for research and clinical use. Patients may benefit from advancements in diagnostics and therapies that rely on these modified DNA products.
Why it matters
Potential benefit: If successful, this research could lead to more affordable and accessible DNA modifications, enhancing the development of new diagnostic tools and treatments.
How similar studies have gone: Previous research has shown promise in developing alternative methods for DNA synthesis, indicating potential for success with this innovative approach.
Where this research is happening
-
Dnali Data Technologies, INC.
Cary, United States Active
Researchers
- Principal investigator: Tomek, Kyle — Dnali Data Technologies, INC.
- Study coordinator: Tomek, Kyle
Related research
Other NIH-funded projects on the same topics.
-
Unbiased amplification of single-stranded DNA oligos for diverse applications
A new platform aims to reliably generate and amplify single-stranded DNA oligos of many lengths for use in genomics, diagnostics, and biotech.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.